Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash & Equivalents (2023 - 2026)

Hinge Health's Cash & Equivalents history spans 3 years, with the latest figure at $208.0 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 30.85% to $208.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $208.0 million, a 30.85% decrease, with the full-year FY2025 number at $208.0 million, down 30.85% from a year prior.
  • Cash & Equivalents hit $208.0 million in Q4 2025 for Hinge Health, down from $261.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for HNGE hit a ceiling of $300.8 million in Q4 2024 and a floor of $208.0 million in Q4 2025.
  • Historically, Cash & Equivalents has averaged $249.5 million across 3 years, with a median of $237.2 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: increased 28.02% in 2024 and later crashed 30.85% in 2025.
  • Tracing HNGE's Cash & Equivalents over 3 years: stood at $235.0 million in 2023, then rose by 28.02% to $300.8 million in 2024, then crashed by 30.85% to $208.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for HNGE at $208.0 million in Q4 2025, $261.3 million in Q3 2025, and $237.2 million in Q2 2025.